The Levothyroxine Sodium for Injecti, cataloged under National Stock Number 6505-01-697-9775, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Fresenius Kabi, Llc. Government technical data includes 3 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: VI.
| Parameter | Value |
|---|---|
| NSN | 6505-01-697-9775 |
| Primary Part Number | NDC63323-0647-10 |
| Item Name | Levothyroxine Sodium for Injecti |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Fresenius Kabi, Llc |
| Status | ACTIVE |
| Administration | INTRAVENOUS |
| Primary Container Type | VIAL, SINGLE DOSE |
| Active Medicament Medicinal Strength | 200.0 MICROGRAMS LEVOTHYROXINE SODIUM EQUIVALENT PER 5 MILLILITERS OF RECONSTITUTED SOLUTION |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | VI |
| Part Number | Manufacturer |
|---|---|
| NDC63323-0647-10 PRIMARY | Fresenius Kabi, Llc (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM217410 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1610613 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-697-9775 is a Levothyroxine Sodium for Injecti, manufactured by Fresenius Kabi, Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-697-9775 has 1 manufacturer part number on file: NDC63323-0647-10 (Fresenius Kabi, Llc).
Key specifications for NDC63323-0647-10: Administration: INTRAVENOUS; Primary Container Type: VIAL, SINGLE DOSE; Special Features: INDICATED FOR THE TREATMENT OF MYXEDEMA COMA; PROTECT FROM LIGHT; STORE DRY PRODUCT AT 20C TO 25 C (68F TO 77 F) (SEE USP CONTROLLED ROOM TEMPERATURE); RECONSTITUTED DRUG PRODUCT IS PRESERVATIVE FREE; DISCARD ANY UNSUSED PORTION; THIS CONTAINER CLOSURE IS NOT MADE WITH NATURAL RUBBER LATEX; FOR INTRAVENOUS USE; SINGLE DOSE VIAL; 200MCG 5ML VIAL.; Part Name Assigned by Controlling Agency: LEVOTHYROXINE SODIUM FOR INJECTION, 5ML. 3 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.